Revenue ($USD) : $489,733,000
R&D spend : $81,679,000.00
Employees : 1,001
Fiscal year end : 12/31/22
CEO : Doug Godshall
The company announced a $500 million private offering to continue its growth. Major medical device companies reportedly saw Shockwave as an acquisition target this year, but Shockwave Medical is a buyer, too. In April, it paid $147 million for Neovasc and its Reducer system for addressing refractory angina. –CN and SW